Pexmetinib Uses, Dosage, Side Effects and more
Pexmetinib is under investigation in clinical trial NCT04074967 (Study of ARRY-614 Plus Either Nivolumab or Ipilimumab).
| Trade Name | Pexmetinib |
| Generic | Pexmetinib |
| Pexmetinib Other Names | Pexmetinib |
| Type | |
| Formula | C31H33FN6O3 |
| Weight | Average: 556.642 Monoisotopic: 556.25981711 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
